The EGFR Protein Expression and the Gene Copy Number Changes in Renal Cell Carcinomas
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background : The epidermal growth factor receptor (EGFR) is known to be involved in many tumor promoting activities. EGFR inhibition has been tried as a therapeutic modality in many human malignancies. Methods : The expression of EGFR protein and the gene copy number changes were studied in 135 clear cell carcinomas and 16 papillary renal cell carcinomas (RCCs), and these tumors were diagnosed between 1995 and 1997. Results : An EGFR protein expression (2+ and 3+) was found in 54.1% of the clear cell RCCs and in 43.8% of the papillary RCCs. In the clear cell RCCs, its expression was associated with male gender, the tumor size (≥4 ㎝) and high T stages (T2 and T3), with statistical significance. Trisomy and polysomy of the EGFR gene were found in 27 (25.7%) and 40 (38.1%) of 105 clear cell RCCs, respectively. Trisomy and polysomy were correlated with an EGFR protein expression and a high clinical T stage, with statistical significance. Among 15 papillary RCCs, 13 tumors showed trisomy (86.7%) and one showed polysomy (6.7%). Amplification was not found in both the clear cell and papillary type RCCs. Conclusions : A considerable numbersof RCCs showed an overexpression of EGFR protein and increased EGFR gene copy numbers, yet the clinical significance of conducting a FISH study in RCC patients seems to be limited.
Abstract
Background : The epidermal growth factor receptor (EGFR) is known to be involved in many tumor promoting activities. EGFR inhibition has been tried as a therapeutic modality in many human malignancies. Methods : The expression of EGFR protein and the gene copy number changes were studied in 135 clear cell carcinomas and 16 papillary renal cell carcinomas (RCCs), and these tumors were diagnosed between 1995 and 1997. Results : An EGFR protein expression (2+ and 3+) was found in 54.1% of the clear cell RCCs and in 43.8% of the papillary RCCs. In the clear cell RCCs, its expression was associated with male gender, the tumor size (≥4 ㎝) and high T stages (T2 and T3), with statistical significance. Trisomy and polysomy of the EGFR gene were found in 27 (25.7%) and 40 (38.1%) of 105 clear cell RCCs, respectively. Trisomy and polysomy were correlated with an EGFR protein expression and a high clinical T stage, with statistical significance. Among 15 papillary RCCs, 13 tumors showed trisomy (86.7%) and one showed polysomy (6.7%). Amplification was not found in both the clear cell and papillary type RCCs. Conclusions : A considerable numbersof RCCs showed an overexpression of EGFR protein and increased EGFR gene copy numbers, yet the clinical significance of conducting a FISH study in RCC patients seems to be limited.
참고문헌 (23)
- Eble JN, "Pathology and genetics of tumours of the urinary system and male genital organs", pp.359~ (2004), Oxford University Press
- Li X, "Prognostic significance of Id-1 and its association with EGFR in renal cell cancer", Histopathology, 50, pp.484~490 (2007)
- Langner C, "Are heterogeneous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation?", J Clin Pathol, 57, pp.773~775 (2004)
- Sibilia M, "The epidermal growth factor receptor: from development to tumorigenesis", Differentiation, 75, pp.770~787 (2007)
- Amare PS, "Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7", Cancer Genet Cytogenet, 125, pp.139~146 (2001)
- Kim H, "Renal cell carcinoma in South Korea:a multicenter study", Hum Pathol, 35, pp.1556~1563 (2004)
- Union Internationale Contre le Cancer (UICC), "Workshop on diagnosis and prognosis of renal cell carcinoma", Cancer, pp.973~1000 (1997)
- Delahunt B, "Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors", Mod Pathol, 10, pp.537~544 (1997)
- Delahunt B, "Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases", Hum Pathol, 32, pp.590~595 (2001)
- de Peralta-Venturina M, "Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases", Am J Surg Pathol, 25, pp.275~284 (2001)
- Fuhrman SA, "Prognostic significance of morphologic parameters in renal cell carcinoma", Am J Surg Pathol, 6, pp.655~663 (1982)
- Mueller-Lisse UG, "Staging of renal cell carcinoma", Eur Radiol, 17, pp.2268~2277 (2007)
- Zandi R, "Mechanisms for oncogenic activation of the epidermal growth factor receptor", Cell Signal, 19, pp.2013~2023 (2007)
- Cappuzzo F, "Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer", J Natl Cancer Inst, 97, pp.643~655 (2005)
- Uberall I, "The status and role of ErbB receptors in human cancer", Exp Mol Pathol, 84, pp.79~89 (2008)
- Cohen D, "The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma:a call for standardized methods for immunohistochemical evaluation", Clin Genitourin Cancer, 5, pp.264~270 (2007)
- Merseburger AS, "Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer", Anticancer Res, 25, pp.1901~1907 (2005)
- Ravaud A, "Epithelial growth factor receptor (EGFR) pathway and renal cell carcinoma", Target Oncol, 2, pp.99~105 (2007)
- Hofmockel G, "Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact", Eur Urol, 31, pp.478~484 (1997)
- Kallio JP, "Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma", Br J Cancer, 89, pp.1266~1269 (2003)
- Stumm G, "Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis", Int J Cancer, 69, pp.17~22 (1996)
- Ishikawa J, "Amplification and overexpression of the epidermal growth factor receptor gene in human renal-cell carcinoma", Int J Cancer, 45, pp.1018~1021 (1990)
- Sargent ER, "Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma", J Urol, 142, pp.1364~1368 (1989)